South Korean multinational Boditech Med Inc to set up R&D facility in India

Jhajjar, India – With highly ambitious plans in India, Boditech Med India, a South Korean multinational specializing in innovative Point-of-Care (POC) diagnostic solutions, plans to triple its sales revenue in five years and set up its research and development facility here.

With a footprint in 140 countries worldwide, Boditech Med moved to its newly constructed production facility in the MET City (Model Economic Township), at Jhajjar near Gurugram, Haryana on Friday. An integrated greenfield smart sustainable city – MET City is a 100% subsidiary of Reliance Industries Limited.

In a conversation with the Asian Community News (ACN) Network, Dr. Eui-Yul Choi, Chairman and CEO of Boditech Med Inc., said, “We project to increase our current sales revenue of 7 USD million to 20 USD million in five years and employ 150 people. We also plan to set up an R&D Facility in India in the near future to tap this country’s high-skilled talent.”

However, Dr. Choi did not disclose the possible location of the R&D facility nor the investment outlay for the new project.

“India represents both a crucial market and an emerging global manufacturing hub for medical devices. The country’s supportive policy framework and growing healthcare infrastructure make it an ideal location for our expansion as we strengthen our commitment to the Indian market,” he added.

Once a professor at a university in Seoul, Dr. Eui-Yul Choi had set up Boditech Med Inc. along with a select group of students.

The Inauguration Ceremony of Boditech Med’s state-of-the-art facility was held in the presence of Lee Seong-Ho, Ambassador of the Republic of Korea to India, Lee Kwang-il, President of Korea Association  in India, Euy Don Park, President of the Federation of Korean Associations in India), Dr. Pramod Kabra (Managing Director, Everlife CPC Diagnostics), and S V Goyal (CEO & Whole-Time Director, MET CITY.

With this inauguration, MET City continues to be a beacon for multinational corporations looking for plug-and-play infrastructure for their manufacturing facility. MET City is now home to 580+ companies from 10 countries, including six from South Korea alone.

Boditech Med Inc. is a South Korean multinational specializing in innovative Point-of-Care (POC) diagnostic solutions. Headquartered in Gangwon-do, South Korea, the company is publicly traded on KOSDAQ and has a presence in 140 countries with a reputation for cutting-edge IVD technologies. Visit www.boditech.co.kr for more.

Boditech Med Inc. has chosen MET City as the site for its new state-of-the-art manufacturing facility under its India subsidiary, Boditech Med India Pvt. Ltd. This move marks a significant milestone in MET City’s growing status as a preferred destination for global MedTech companies and further strengthens its position as India’s leading greenfield smart sustainable industrial township.

The new facility by Boditech Med aligns seamlessly with the Government of India’s Make in India and Atmanirbhar Bharat initiatives.

S.V. Goyal, CEO & WTD of MET City, said, “We’re pleased to welcome Boditech Med to MET City’s growing roster of global companies. As a leading Greenfield Smart Sustainable City with companies from 10 countries utilizing our Plug-n-Play infrastructure, MET City has become a destination of choice for diverse industries. Boditech Med’s state-of-the-art facility strengthens our position as an emerging medical device manufacturing hub. We look forward to welcoming more South Korean enterprises to our township at Jhajjar as India’s industrial landscape evolves. Boditech Med’s investment is poised to create local employment, empower small businesses, and position MET City as a key node in the global medical devices value chain.”